Glenn Reicin

Glenn Reicin

Director Financiero/CFO en HARMONY BIOSCIENCES HOLDINGS, INC. .
61 años
Finance
Health Technology
Consumer Services

Perfil

Glenn M.
Reicin
is Chief Financial Officer at Harmony Biosciences Holdings, Inc. since 2026.
Former roles include Chief Financial Officer & Treasurer at Sigilon Therapeutics, Inc. from 2019 to 2021; President at Greyrock Biomedical Advisors Ltd. from 2013 to 2019; Director at Novasys Medical, Inc. from 2009 to 2013; Director at SpinalMotion, Inc. from 2009 to 2014; Director at SI-BONE, Inc. from 2010 to 2012; Managing Director at Morgan Stanley & Co. LLC from 1993 to 2008; Managing Director at Skyline Management LLC from 2009 to 2012; Independent Director at Amplitude Healthcare Acquisition Corp.; Analyst at Fidelity Management & Research Co. LLC; Senior Vice President at Oppenheimer & Co., Inc.; Management Consultant at Bain & Co., Inc.; and Chief Financial & Operating Officer at Alladapt Immunotherapeutics, Inc. Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.

Cargos activos de Glenn Reicin

EmpresasCargoInicio
HARMONY BIOSCIENCES HOLDINGS, INC. Director Financiero/CFO 14/04/2026

Antiguos cargos conocidos de Glenn Reicin.

EmpresasCargoFin
SIGILON THERAPEUTICS, INC. Director Financiero/CFO 14/06/2021
Presidente 01/05/2019
Director/Miembro de la Junta 01/01/2014
Director/Miembro de la Junta 01/01/2013
Inversor de Capital Privado 01/01/2012
Ver el detalle de la experiencia de Glenn Reicin.

Formación de Glenn Reicin.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

98

Relaciones de 1er grado

15

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas15

Finance

Finance

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Finance

Health Technology